Madison Greg 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Oct 6, 2017
Insider Transaction Report
Form 4
Madison Greg
DirectorPresident and CEO
Transactions
- Sale
Common Stock
[F1][F2]2017-10-05$7.19/sh−895$6,435→ 372,742 total
Footnotes (2)
- [F1]Sale of a total of 895 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 2,823 shares of restricted stock on October 4, 2017. Mr. Madison had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 229,695 shares of restricted stock.
Signature
/s/ Brian Adams, Attorney-in-Fact|2017-10-06